Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-000478

Chief Executive Officer sold 9,952 shares at an average $31.01 ($308,637)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2024-01-02 Sale 10b5-1 −4,634 $30.74 $142,449 3,720,366 D: show line 1 in the form
Anzalone Christopher Richard Chief Executive Officer 2024-01-02 Sale 10b5-1 −5,318 $31.25 $166,188 3,715,048 D: show line 2 in the form
Open-market sales · 9,952 sh · avg $31.01 · $308,637
Loading xslF345X05/wk-form4_1704407090.xml…